SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001619856-23-000107
Filing Date
2023-08-08
Accepted
2023-08-08 16:06:44
Documents
85
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crbu-20230630.htm   iXBRL 10-Q 1176108
2 EX-31.1 crbu-20230630xexx311.htm EX-31.1 9498
3 EX-31.2 crbu-20230630xexx312.htm EX-31.2 9502
4 EX-32.1 crbu-20230630xexx321.htm EX-32.1 4658
5 EX-32.2 crbu-20230630xexx322.htm EX-32.2 4647
  Complete submission text file 0001619856-23-000107.txt   7183858

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20230630.xsd EX-101.SCH 53127
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crbu-20230630_cal.xml EX-101.CAL 67721
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crbu-20230630_def.xml EX-101.DEF 258429
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20230630_lab.xml EX-101.LAB 643245
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20230630_pre.xml EX-101.PRE 457380
79 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20230630_htm.xml XML 1072107
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40631 | Film No.: 231151227
SIC: 2836 Biological Products, (No Diagnostic Substances)